Meyron

Reference summary — not medical advice or a personal risk estimate.

Tamoxifen

Group 1 — carcinogenic to humansMedications & MedicalbehavioralEvidence: sufficient_in_humans

Quick answer

Classified as Group 1 — carcinogenic to humans, based on sufficient evidence in humans. Prescription medication. Used to treat hormone-receptor-positive breast cancer.

Summary

Used to treat hormone-receptor-positive breast cancer; also classified by IARC as a cause of endometrial cancer.

Detail

Tamoxifen is a selective oestrogen-receptor modulator. IARC classified it as Group 1 with sufficient evidence for endometrial cancer. It is widely prescribed for hormone-receptor-positive breast cancer; patients taking it are typically monitored by their oncology team for endometrial changes. This entry exists because tamoxifen appears on the IARC Group 1 list; clinical decisions about whether to take it are between a patient and their clinician.

What's not established

This classification is based on sufficient evidence in humans that this factor can cause cancer. It does not establish a safe exposure threshold, your personal risk, or how this factor's risk compares in size to other Group 1 agents — hazard classifications are not ranked by magnitude.

Regional relevance

global

global

Documented in these products

Presence in a product category doesn't imply the product causes cancer. Click each to see the source and context.

Evidence sources

Every claim on this page traces back to one of these. Click through to read the primary document yourself.

Primary sources

IARC

IARC Monographs — Classifications by Cancer Site, Vols 1–140

View source →

Supporting sources

ACS

ACS — Known and Probable Human Carcinogens

View source →

Cancer Research UK

Cancer Research UK — Causes of cancer and reducing your risk

View source →

NTP

NTP — Report on Carcinogens (US National Toxicology Program)

View source →

Last reviewed: October 2026

Official reference list

A government list some readers use alongside the primary evidence. Meyron is not affiliated with it. A chemical being listed does not by itself describe a risk from any particular product.